These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1195999)

  • 1. Decrease of calcium turnover during the onset of mineralocorticoid hypertension in the rat.
    Stoclet JC; Miss-Pagès C; Berthelot A; Gairard A
    Life Sci; 1975 Oct; 17(7):1095-103. PubMed ID: 1195999
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relationship between the level of mineralocorticoid arterial hypertension and calcium metabolism in the rat].
    Miss-Pages C; Gairard A
    C R Seances Soc Biol Fil; 1975; 169(3):700-5. PubMed ID: 129220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evolution of calcium metabolism during mineralocorticoid hypertension in the rat].
    Gairard A; Stoclet JC; Miss C
    C R Seances Soc Biol Fil; 1973; 167(12):1977-82. PubMed ID: 4802898
    [No Abstract]   [Full Text] [Related]  

  • 4. [Arterial blood pressure and high calcium diet in normal and mineralcorticoid (DOCA and sodium chloride hypertensive rats].
    Pernot F; Berthelot A; Gairard A
    C R Seances Soc Biol Fil; 1978; 172(6):1214-9. PubMed ID: 227548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The parathyroids and desoxycorticosterone acetate induced arterial hypertension in the rat].
    Berthelot A; Schleiffer R; Gairard A
    Can J Physiol Pharmacol; 1979 Feb; 57(2):157-62. PubMed ID: 546483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary chloride as a determinant of disordered calcium metabolism in salt-dependent hypertension.
    Kurtz TW; Morris RC
    Life Sci; 1985 Mar; 36(10):921-9. PubMed ID: 2983159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of high calcium diet on arterial smooth muscle function and electrolyte balance in mineralocorticoid-salt hypertensive rats.
    Arvola P; Ruskoaho H; Pörsti I
    Br J Pharmacol; 1993 Apr; 108(4):948-58. PubMed ID: 8485634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that a GABAergic mechanism influences the development of DOCA-salt hypertension in the rat.
    Rotiroti D; Palella B; Losi E; Nistico G; Caputi AP
    Eur J Pharmacol; 1982 Sep; 83(1-2):153-4. PubMed ID: 6813130
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcium supplementation inhibits the expression of parathyroid hypertensive factor in DOCA-salt hypertensive rats.
    Lin CM; Saito K; Tsujino T; Yokoyama M
    Am J Hypertens; 1994 Feb; 7(2):201-4. PubMed ID: 8179855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal nerves are not necessary for onset or maintenance of DOC-salt hypertension in rats.
    Dzielak DJ; Norman RA
    Am J Physiol; 1985 Nov; 249(5 Pt 2):H945-9. PubMed ID: 4061671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of central serotonin depletion on DOCA-saline hypertension in the rat.
    Myers MG; Reid JL; Lewis PJ
    Cardiovasc Res; 1974 Nov; 8(6):806-10. PubMed ID: 4457231
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of chloride in deoxycorticosterone hypertension: selective sodium loading by diet or drinking fluid.
    Kunes J; Zicha J; Jelínek J
    Physiol Res; 2004; 53(2):149-54. PubMed ID: 15046550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effect of progesterone in rats with mineralocorticoid-induced hypertension.
    Wambach G; Higgins JR
    Am J Physiol; 1979 Apr; 236(4):E366-70. PubMed ID: 434199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelationships of sodium intake, hypertension, and norepinephrine storage in the rat.
    de Champlain J; Krakoff L; Axelrod J
    Circ Res; 1969 May; 24(5):Suppl:75-92. PubMed ID: 5793748
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance to mineralocorticoids in Wistar-Furth rats.
    Ullian ME; Islam MM; Robinson CJ; Fitzgibbon WR; Tobin ET; Paul RV
    Am J Physiol; 1997 Mar; 272(3 Pt 2):H1454-61. PubMed ID: 9087624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in endogenous phosphodiesterase activator content of rat aorta.
    Lugnier C; Ilien B; Stoclet JC
    Eur J Pharmacol; 1978 Dec; 53(1):109-12. PubMed ID: 216558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of verapamil on blood pressure and lesions in heart and kidney of rats made hypertensive by deoxycorticosterone (DOC).
    Aguas AP; Nickerson PA
    Am J Pathol; 1983 Jan; 110(1):48-54. PubMed ID: 6849371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spironolactone inhibits the activity of the Na+/H+ exchanger in the aorta of mineralocorticoid-induced hypertensive rats.
    Carreño JE; Verdugo FJ; Contreras F; Montellano FA; Veloso S; Schalper KA; Sandoval M; Villanueva S; Marusic E; Irarrazabal CE
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1225-31. PubMed ID: 25997821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chloride on blood pressure and sympathetic nervous system activity in deoxycorticosterone acetate-treated rats.
    Miki T; Sano H; Suzuki H; Kawahara J; Hattori K; Saito K; Furuta Y; Fukuzaki H
    Am J Hypertens; 1989 Apr; 2(4):253-5. PubMed ID: 2706092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I. PTH and U. cAMP during mineralocorticoid hypertension in the rat.
    Berthelot A; Desplan C; Pernot F; Gairard A
    Horm Metab Res; 1978 Jan; 10(1):83-4. PubMed ID: 204568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.